RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Total non-current assets

VERTEX PHARMACEUTICALS INCVRTX

Market cap
$109.6B
P/E ratio
SummaryFinancials
Period EndTotal non-current assets (Million USD)YoY (%)
Dec 31, 202412,937+50.67%
Dec 31, 20238,586+74.65%
Dec 31, 20224,916+26.97%
Dec 31, 20213,872+7.01%
Dec 31, 20203,618+3.51%
Dec 31, 20193,496+45.48%
Dec 31, 20182,403+167.85%
Dec 31, 2017897-15.79%
Dec 31, 20161,065-2.43%
Dec 31, 20151,092+38.51%
Dec 31, 2014788+7.90%
Dec 31, 2013730-37.55%
Dec 31, 20121,170+33.98%
Dec 31, 2011873+30.61%
Dec 31, 2010668

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)